The Janus Kinase Inhibitor, JAB/SOCS-1, Is an Interferon-γ Inducible Gene and Determines the Sensitivity to Interferons

References

• Damell J. E., Jr. STATs and Gene Regulation. Science 1997; 277: 1630–1635
   PubMed Web of Science ®Google Scholar
• Hoey T., Schindler U. STAT structure and function in signaling. Curr, Opin. Genet. Dev. 1998; 8: 582–587
   PubMed Web of Science ®Google Scholar
• Liu K. D., Gaffen S. L., Goldsmith M. A. JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 1998; 10: 271–278
   PubMed Web of Science ®Google Scholar
• Leonard W. J., O'Shea J. J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998; 16: 293–322
   PubMed Web of Science ®Google Scholar
• Kim T. K., Maniatis T. Regulation of inter-feron-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 1996; 273: 1717–1719
   PubMed Web of Science ®Google Scholar
• Strous G. J., van Kerkhof P., Govers R., Ciechanover A., Schwartz A. L. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J 1996; 15: 3806–3812
   PubMed Web of Science ®Google Scholar
• Callus B. A., Mathey-Prevot B. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood 1998; 91: 3182–3192
   PubMed Web of Science ®Google Scholar
• Wang D., Stravopodis D., Teglund S., Kitazawa J., Ihle J. N. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 1996; 16: 6141–6148
   PubMedGoogle Scholar
• Azam M., Lee C., Strehlow I., Schindler C. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 1997; 6: 691–701
   PubMedGoogle Scholar
• Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduc-tion by PIAS3. Science 1997; 278: 1803–1805
   PubMed Web of Science ®Google Scholar
• Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D., Shuai K. Inhibition of Statl-mediated gene activation by PIASI. Proc. Natl. Acad. Sci. USA 1998; 95: 10626–10631
   PubMed Web of Science ®Google Scholar
• Migone T. S., Cacalano N. A., Taylor N., Yi T., Waldmann T. A., Johnston J. A. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci, USA 1998; 95: 3845–3850
   PubMed Web of Science ®Google Scholar
• David M., Chen H. E., Goelz S., Lamer A. C., Neel B. G. Differential regulation of the alphaheta inter-feron-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTPI. Mol. Cell. Biol. 1995; 15: 7050–7058
   PubMed Web of Science ®Google Scholar
• Shu cell protein-tyrosine phosphatase (Hcph) gene. Cell, 73: 1445–1454
   PubMed Web of Science ®Google Scholar
• You M., Yu D. H., Feng G. S. Shp-2 tyrosine phosphatase functions as a negative regulator of the inter-feron-stimulated Jak/STAT pathway. Mol. Cell. Biol. 1999; 19: 2416–2424
   PubMed Web of Science ®Google Scholar
• Liu Q., Sasaki T., Kozieradzki I., Wakeham A., Itie A., Dumont D. J., Penninger J. M. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 1999; 13: 786–791
   PubMed Web of Science ®Google Scholar
• Ueno H., Sasaki K., Miyagawa K., Honda H., Mitani K., Yazaki Y., Hirai H. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem. 1997; 272: 8739–8743
   PubMed Web of Science ®Google Scholar
• Yoshimura A. The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia 1998; 12: 1851–1857
   PubMed Web of Science ®Google Scholar
• Yoshimura A. The CIS family: negative regulators of JAK-STAT signaling. Cytokine Growth Factor Rev 1998; 9: 197–204
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N. A., Gilbert D. J., Copeland N. G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2 containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBOJ. 1995; 14: 2816–2826
   PubMed Web of Science ®Google Scholar
• Uchida K., Yoshimura A., Inazawa J., Yanagisawa K., Osada H., Masuda A., Saito T., Takahashi T., Miyajima A., Takahashi T. Molecular cloning of CISH, chromosome assignment to 3p21. 3, and analysis of expression in fetal and adult tissues. Cytogenet. Cell. Genet. 1997; 78: 209–212
   PubMedGoogle Scholar
• Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997; 89: 3148–3154
   PubMed Web of Science ®Google Scholar
• Verdier R., Chretien S., Muller O., Varlet P., Yoshimura A., Gisselbrecht S., Lacombe C., Mayeux P. Proteasomes Regulate Erythropoietin Receptor and Signal Transducer and Activator of Transcription 5 (STAT5) Activation. POSSIBLE INVOLVEMENT OF THE UBIQUITINATED CIS PROTEIN. J. Biol. Chem. 1998; 273: 28185–28190
   PubMed Web of Science ®Google Scholar
• Matsumoto A., Seki Y., Kubo M., Ohtsuka S., Suzuki A., Hayashi I., Tsuji K., Nakahata T., Okabe M., Yamada S., Yoshimura A. Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice. Mol. Cell Biol. 1999; 19: 6396–6407
   PubMed Web of Science ®Google Scholar
• Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A., Waxman D. J., Davey H. W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 1997; 94: 7239–7244
   PubMed Web of Science ®Google Scholar
• Liu X., Robinson G. W., Wagner K. U., Garrett L., Wyn-shaw-Boris A., Hennighausen L. StatSa is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997; 11: 179–186
   PubMed Web of Science ®Google Scholar
• Nakajima H., Liu X. W., Wynshaw-Boris A., Rosenthal L. A., Imada K., Finbloom D. S., Hennighausen L., Leonard W. J. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for StatSa in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997; 7: 691–701
   PubMed Web of Science ®Google Scholar
• Teglund S., McKay C., Schuetz E., van Deursen J. M., Stra-vopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J. N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998; 93: 841–850
   PubMed Web of Science ®Google Scholar
• Moriggl R., Topham D. J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M. Y., Bunting K. D., Grosveld G. C., Ihle J. N. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999; 10: 249–259
   PubMedGoogle Scholar
• Stan R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton D. J. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917–921
   PubMed Web of Science ®Google Scholar
• Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921–924
   PubMed Web of Science ®Google Scholar
• Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924–929
   PubMed Web of Science ®Google Scholar
• Masuhara M., Sakamoto H., Matsumoto A., Suzuki R., Yasukawa H., Mitsui K., Wakioka T., Tanimura S., Sasaki A., Misawa H., Yokouchi M., Ohtsubo M., Yoshimura A. Cloning and Characterization of Novel CIS Family Genes. Biochem. Biophys. Res. Commun. 1997; 239: 439–446
   PubMedGoogle Scholar
• Hilton D. J., Richardson R. T., Alexander W. S., Viney E. M., Willson T. A., Sprigg N. S., Stan R., Nicholson S. E., Metcalf D., Nicola N. A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 1998; 95: 114–119
   PubMed Web of Science ®Google Scholar
• Kamura T., Sato S., Haque D., Liu L., Kaelin W. G., Jr, Conaway R. C., Conaway J. W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 1998; 12: 3872–3881
   PubMed Web of Science ®Google Scholar
• Zhang J. G., Farley A., Nicholson S. E., Willson T. A., Zugaro L. M., Simpson R. J., Moritz R. L., Cary D., Richardson R., Hausmann G., Kile B. J., Kent S. B., Alexander W. S., Metcalf D., Hilton D. J., Nicola N. A., Baca M. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 1999; 96: 2071–2076
   PubMed Web of Science ®Google Scholar
• Suzuki R., Sakamoto H., Yasukawa H., Masuhara M., Wakioka T., Sasaki A., Yuge K., Komiya S., Inoue A., Yoshimura A. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in MI leukemia cells. Oncogene 1998; 17: 2271–2278
   PubMed Web of Science ®Google Scholar
• Sakamoto H., Yasukawa H., Masuhara M., Tanimura S., Sasaki A., Yuge K., Ohtsubo M., Ohtsuka S., Fujita T., Ohta T., Furukawa Y., Iwase S., Yamada H., Yoshimura A. A Janus kinase inhibitor, JAB, is an inter-feron-gamma-inducible gene and confers resistance to inter-ferons. Blood 1998; 92: 1668–1676
   PubMed Web of Science ®Google Scholar
• Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y., Kishimoto T. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 1998; 95: 15577–15582
   PubMed Web of Science ®Google Scholar
• Starr R., Metcalf D., Elefanty A. G., Brysha M., Willson T. A., Nicola N. A., Hilton D. J., Alexander W. S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Nail. Acad. Sci. USA 1998; 95: 14395–14399
   PubMed Web of Science ®Google Scholar
• Alexander W. S., Starr R., Fenner J. E., Scott C. L., Handman E., Sprigg N. S., Corbin J. E., Cornish A. L., Darwiche R., Owczarek C. M., Kay T. W. H., Nicola N. A., Hertzog P. J., Metcalf D., Hilton D. J. SOCSl Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this. Cytokine. Cell 1999; 98: 597–608
   Google Scholar
• Marine J. -C., Topham D. J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J. N. SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality. Cell 1999; 98: 609–616
   PubMedGoogle Scholar
• Metcalf D., Alexander W. S., Elefanty A. G., Nicola N. A., Hilton D. J., Starr R., Mifsud S., Di Rago L. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia 1999; 13: 926–934
   PubMed Web of Science ®Google Scholar
• Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J. N., Yoshimura A. The JAK-Binding Protein JAB Inhibits Janus vrosine Kinase Activity Through Binding in the Activation Loop. EMBOJ. 1999; 18: 1309–1320
   PubMed Web of Science ®Google Scholar
• Nicholson S. E., Willson T. A., Farley A., Starr R., Zhang J. G., Baca M., Alexander W. S., Metcalf D., Hilton D. J., Nicola N. A. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 1999; 18: 375–385
   PubMed Web of Science ®Google Scholar
• Sasaki A., Yasukawa H., Suzuki A., Kamizono S., Syoda T., Kinjyo I., Sasaki M., Johnston J. A., Yoshimura A. Cytokine-inducible SH2 protein-3 (CIS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes to Cells 1999; 4: 339–351
   PubMed Web of Science ®Google Scholar
• Marine J. -C., McKay C., Wang D., Topham D. J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A., Ihle J. N. SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis. Cell 1999; 98: 617–627
   PubMed Web of Science ®Google Scholar